CITADEL ADVISORS LLC - 15 Jan 2026 SCHEDULE 13G Report for BriaCell Therapeutics Corp. Common Shares, no par value per share (the "Shares") (BCTX)

Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Security
BriaCell Therapeutics Corp. Common Shares, no par value per share (the "Shares")
Symbol
BCTX
Shares outstanding
7,179,159 shares
Disclosed Ownership
717,198 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
23 Jan 2026, 18:59:18 UTC
Date of event
15 Jan 2026
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 10% 716,699 0 716,699 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 10% 716,699 0 716,699 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 10% 716,699 0 716,699 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0% 499 0 499 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities Group LP 0% 499 0 499 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities GP LLC 0% 499 0 499 /s/ Seth Levy Seth Levy, Authorized Signatory
Kenneth Griffin 10% 717,198 0 717,198 /s/ Seth Levy Seth Levy, attorney-in-fact*